Critical Review: Rock Creek Pharmaceuticals (OTCMKTS:RCPIQ) & biote (NASDAQ:BTMD)

biote (NASDAQ:BTMD) and Rock Creek Pharmaceuticals (OTCMKTS:RCPIQ) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership and dividends.

Profitability

This table compares biote and Rock Creek Pharmaceuticals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
biote	5.20%	-32.41%	22.26%
Rock Creek Pharmaceuticals	N/A	N/A	N/A

Institutional and Insider Ownership

21.7% of biote shares are owned by institutional investors. 13.9% of biote shares are owned by insiders. Comparatively, 0.9% of Rock Creek Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares biote and Rock Creek Pharmaceuticals”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
biote	$185.36 million	1.37	$3.32 million	$0.26	17.92
Rock Creek Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

biote has higher revenue and earnings than Rock Creek Pharmaceuticals.

Analyst Recommendations

This is a breakdown of current ratings and price targets for biote and Rock Creek Pharmaceuticals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
biote	0	0	3	0	3.00
Rock Creek Pharmaceuticals	0	0	0	0	0.00

biote currently has a consensus price target of $10.00, indicating a potential upside of 114.59%. Given biote’s stronger consensus rating and higher possible upside, equities research analysts plainly believe biote is more favorable than Rock Creek Pharmaceuticals.

Summary

biote beats Rock Creek Pharmaceuticals on 8 of the 9 factors compared between the two stocks.

About biote

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

About Rock Creek Pharmaceuticals

Rock Creek Pharmaceuticals, Inc. is an early stage life science company, which engages in the discovery, development, and commercialization of new drugs, formulations, and compounds that provide therapies for chronic and acute inflammatory diseases. It focuses on small molecule therapeutics that exhibit anti-inflammatory pharmacological characteristics. The company was founded by Jonnie R. Williams, Sr. on June 24, 1985 and is headquartered in Sarasota, FL.